Cargando…
Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer
Breast cancer is the leading cause of death by malignancy among women worldwide. Clinical data and molecular characteristics of breast tumors are essential to guide clinician’s therapeutic decisions. In the new era of precision medicine, that aims at personalizing the treatment for each patient, the...
Autores principales: | Haykal, Maria M., Rodrigues-Ferreira, Sylvie, Nahmias, Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147298/ https://www.ncbi.nlm.nih.gov/pubmed/34062782 http://dx.doi.org/10.3390/cells10051080 |
Ejemplares similares
-
AT2 Receptor-Interacting Proteins ATIPs in the Brain
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2013) -
Negative regulation of EB1 turnover at microtubule plus ends by interaction with microtubule-associated protein ATIP3
por: Velot, Lauriane, et al.
Publicado: (2015) -
ATIP3 deficiency facilitates intracellular accumulation of paclitaxel to reduce cancer cell migration and lymph node metastasis in breast cancer patients
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2020) -
The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer
por: Louis, Simon N.S., et al.
Publicado: (2011) -
8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2009)